Top in hem/onc: Safety communication on breast implants; cancer benefits of seaweed sugar
Click Here to Manage Email Alerts
Last week, the FDA issued a safety communication stating that it has identified cases of squamous cell carcinoma in scar tissue that formed around breast implants.
The agency previously issued a safety alert in September informing the public about reports of cancers — including squamous cell carcinomas and certain lymphomas — being found in scar tissue surrounding breast implants. The FDA released its updated safety communication to share findings of its review of literature and medical device reports. It was the top story in hematology/oncology last week.
Another top story was about the potential for seaweed sugar to inhibit the metastasis of melanoma and improve the effectiveness of immunotherapy.
Read these and more top stories in hematology/oncology below:
FDA issues safety communication about cancers in scar tissue around breast implants
The FDA is aware of 19 cases of squamous cell carcinoma in scar tissue that forms around breast implants, the agency announced today in a safety communication. Read more.
Seaweed sugar could improve efficacy of immunotherapy in melanoma
Although immunotherapies have been a game-changer in cancer treatment, they do not work for all patients. Read more.
More than half of ED visits among patients with cancer ‘potentially preventable’
More than half of ED visits between 2012 and 2019 among adults with cancer potentially could have been prevented, according to study results published in JAMA Network Open. Read more.
Large-scale 2D, 3D maps could enable ‘much more precise’ cancer diagnosis, treatment
Traditional histology typically guides treatment decisions for patients with colorectal cancer and various other malignancies, but it is unable to reveal a tumor’s molecular or structural features. Read more.
Inequalities persist for female, Black faculty among well-funded NIH investigators
The proportion of female and Black faculty among a cohort of well-funded NIH investigators appeared to be significantly lower compared with white men, according to study results published in JAMA Network Open. Read more.